| Viruses as vaccine vectors for infectious diseases and cancer SJ Draper, JL Heeney Nature Reviews Microbiology 8 (1), 62-73, 2010 | 474 | 2010 |
| Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization KD Brune, DB Leneghan, IJ Brian, AS Ishizuka, MF Bachmann, SJ Draper, ... Scientific Reports 6, 19234, 2016 | 426 | 2016 |
| Malaria Vaccines: Recent Advances and New Horizons SJ Draper, BK Sack, CR King, CM Nielsen, JC Rayner, MK Higgins, ... Cell host & microbe 24 (1), 43-56, 2018 | 407 | 2018 |
| Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ... Nature communications 4, 2013 | 375 | 2013 |
| The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody AD Douglas, AR Williams, JJ Illingworth, G Kamuyu, S Biswas, ... Nature communications 2 (1), 601, 2011 | 328 | 2011 |
| A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ... N Engl J Med 2016 (374), 1635-1646, 2016 | 314 | 2016 |
| A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys AD Douglas, GC Baldeviano, CM Lucas, LA Lugo-Roman, C Crosnier, ... Cell host & microbe 17 (1), 130-139, 2015 | 267 | 2015 |
| Erythroferrone inhibits the induction of hepcidin by BMP6 J Arezes, N Foy, K McHugh, A Sawant, D Quinkert, V Terraube, A Brinth, ... Blood 132 (14), 1473-1477, 2018 | 265 | 2018 |
| ChAd63-MVA–vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans SH Sheehy, CJA Duncan, SC Elias, P Choudhary, S Biswas, FD Halstead, ... Molecular Therapy 20 (12), 2355-2368, 2012 | 256 | 2012 |
| Prime-boost vectored malaria vaccines: progress and prospects AV Hill, A Reyes-Sandoval, G O’Hara, K Ewer, A Lawrie, A Goodman, ... Hum Vaccin 6 (1), 78-83, 2010 | 249 | 2010 |
| Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination TUJ Bruun, AMC Andersson, SJ Draper, M Howarth ACS nano 12 (9), 8855-8866, 2018 | 241 | 2018 |
| Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies KE Wright, KA Hjerrild, J Bartlett, AD Douglas, J Jin, RE Brown, ... Nature 515 (7527), 427-430, 2014 | 228 | 2014 |
| Effective induction of high-titer antibodies by viral vector vaccines SJ Draper, AC Moore, AL Goodman, CA Long, AA Holder, SC Gilbert, ... Nature medicine 14 (8), 819-821, 2008 | 209 | 2008 |
| Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors SH Sheehy, CJA Duncan, SC Elias, KA Collins, KJ Ewer, AJ Spencer, ... Molecular Therapy 19 (12), 2269-2276, 2011 | 207 | 2011 |
| Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors SH Sheehy, CJA Duncan, SC Elias, S Biswas, KA Collins, GA O'Hara, ... PLoS One 7 (2), e31208, 2012 | 199 | 2012 |
| Neutralization of Plasmodium falciparum Merozoites by Antibodies against PfRH5 AD Douglas, AR Williams, E Knuepfer, JJ Illingworth, JM Furze, ... The Journal of Immunology 192 (1), 245-258, 2014 | 180 | 2014 |
| Coated microneedle arrays for transcutaneous delivery of live virus vaccines A Vrdoljak, MG McGrath, JB Carey, SJ Draper, AVS Hill, C O'Mahony, ... Journal of Controlled Release 159 (1), 34-42, 2012 | 167 | 2012 |
| Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions RO Payne, SE Silk, SC Elias, K Miura, A Diouf, F Galaway, H de Graaf, ... JCI insight 2 (21), 2017 | 154 | 2017 |
| Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens AR Williams, AD Douglas, K Miura, JJ Illingworth, P Choudhary, ... PLoS pathogens 8 (11), e1002991, 2012 | 152 | 2012 |
| In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination J Bayry, EZ Tchilian, MN Davies, EK Forbes, SJ Draper, SV Kaveri, ... Proceedings of the National Academy of Sciences 105 (29), 10221-10226, 2008 | 152 | 2008 |
Sarah C GilbertProfessor of Vaccinology, Pandemic Sciences Institute, Oxford UniversityVerified email at ndm.ox.ac.uk
